Pharming (PHAR) Payables (2019 - 2026)
Pharming's (PHAR) quarterly Payables came in at $82.3 million in Q2 2026, up 5.03% YoY from $78.4 million in Q2 2025, and down 20.48% on a QoQ basis from $103.5 million in Q1 2026.
Pharming (PHAR) Payables (2019 - 2026) Analysis & Trends
Pharming (PHAR) has 8 years of Payables data on file, last reported at $82.3 million in Q2 2026.
- Quarterly Payables rose 5.03% year-over-year to $82.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $82.3 million (up 5.03% YoY) and the FY2025 annual result came in at $105.9 million, up 58.98% from the prior year.
- Payables retreated to $82.3 million in Q2 2026, from $103.5 million in the prior quarter.
- In the past five years, Payables ranged from a high of $105.9 million in Q4 2025 to a low of $42744.0 in Q3 2022.
- A 5-year average of $65.9 million and a median of $68.6 million in 2024 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables tumbled 99.9% — and 2023, when it surged 146212.93%.
- Tracing PHAR's Payables over 5 years: stood at $54.5 million in 2022, then jumped by 33.16% to $72.5 million in 2023, then slipped by 8.16% to $66.6 million in 2024, then soared by 58.98% to $105.9 million in 2025, then slipped by 22.26% to $82.3 million in 2026.
- The last three Payables figures came in at $82.3 million (Q2 2026), $103.5 million (Q1 2026), and $105.9 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn | 82.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 82.32 Mn |
| Mar 31, 2026 | 103.53 Mn |
| Dec 31, 2025 | 105.90 Mn |
| Sep 30, 2025 | 78.22 Mn |
| Jun 30, 2025 | 78.38 Mn |
| Mar 31, 2025 | 68.75 Mn |
| Dec 31, 2024 | 66.61 Mn |
| Sep 30, 2024 | 72.64 Mn |
| Jun 30, 2024 | 72.97 Mn |
| Mar 31, 2024 | 68.52 Mn |
| Dec 31, 2023 | 72.53 Mn |
| Sep 30, 2023 | 62.54 Mn |
| Jun 30, 2023 | 59.30 Mn |
| Mar 31, 2023 | 53.25 Mn |
| Dec 31, 2022 | 54.47 Mn |
| Sep 30, 2022 | 42,744.00 |
| Jun 30, 2022 | 45.07 Mn |
| Mar 31, 2022 | 40.83 Mn |
| Dec 31, 2021 | 20.36 Mn |
| Sep 30, 2021 | 42.15 Mn |